Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$105.0 - $178.37 $27.4 Million - $46.6 Million
-261,000 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$125.11 - $180.0 $3.67 Million - $5.27 Million
29,300 Added 12.65%
261,000 $46.2 Million
Q1 2021

May 06, 2021

BUY
$126.27 - $191.71 $29 Million - $44 Million
229,600 Added 10933.33%
231,700 $30.9 Million
Q4 2020

Feb 09, 2021

SELL
$81.94 - $135.34 $1.68 Million - $2.77 Million
-20,500 Reduced 90.71%
2,100 $284,000
Q3 2020

Nov 05, 2020

SELL
$73.3 - $89.48 $17 Million - $20.7 Million
-231,800 Reduced 91.12%
22,600 $1.88 Million
Q2 2020

Jul 29, 2020

BUY
$48.82 - $82.53 $7.68 Million - $13 Million
157,300 Added 162.0%
254,400 $20.9 Million
Q1 2020

May 11, 2020

SELL
$39.1 - $62.9 $89,930 - $144,670
-2,300 Reduced 2.31%
97,100 $5 Million
Q4 2019

Feb 04, 2020

BUY
$29.79 - $43.06 $530,262 - $766,468
17,800 Added 21.81%
99,400 $4.13 Million
Q3 2019

Nov 05, 2019

BUY
$30.47 - $37.65 $639,870 - $790,650
21,000 Added 34.65%
81,600 $2.64 Million
Q2 2019

Aug 06, 2019

SELL
$25.73 - $35.79 $182,683 - $254,109
-7,100 Reduced 10.49%
60,600 $2.11 Million
Q1 2019

May 06, 2019

BUY
$21.71 - $31.54 $1.22 Million - $1.77 Million
56,061 Added 481.67%
67,700 $2 Million
Q4 2018

Feb 06, 2019

BUY
$14.95 - $24.72 $174,003 - $287,716
11,639 New
11,639 $270,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.59B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Matthews International Capital Management LLC Portfolio

Follow Matthews International Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.